Business Wire

Enveda Advances Third Asset to the Clinic With US FDA IND Clearance and Phase 1 Initiation of ENV-6946, a First-in-Class Oral “Multi-Biologic in a Pill” for Inflammatory ...

BOULDER, Colo.--(BUSINESS WIRE)--Enveda, a multi-asset clinical-stage biotech company pioneering the discovery and development of a new generation of small-molecule drugs derived from life’s chemistry ...
Business Wire

Enveda Expands into Asthma with First-in-Class Lead Asset ENV-294 and Assembles World-Class Advisory Board

BOULDER, Colo.--(BUSINESS WIRE)--Enveda, a biotechnology company using AI to translate nature into new medicines, is proud to announce testing of its lead asset, ENV-294, in a second indication: ...
The American Journal of Managed Care

Deep Learning Biomarkers Help Uncover ENV-101 Treatment Effects in IPF

Novel CT-based tools and AI models effectively detect lung volume and fibrosis changes in IPF patients treated with ENV-101. ENV-101 treatment resulted in significant increases in lung volume and ...
ZDNet

Botnets have been silently mass-scanning the internet for unsecured ENV files

Drawing little attention to themselves, multiple threat actors have spent the past two-three years mass-scanning the internet for ENV files that have been accidentally uploaded and left exposed on web ...